These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 7677190)
1. p53 gene mutations, p53 protein accumulation and compartmentalization in colorectal adenocarcinoma. Bosari S; Viale G; Roncalli M; Graziani D; Borsani G; Lee AK; Coggi G Am J Pathol; 1995 Sep; 147(3):790-8. PubMed ID: 7677190 [TBL] [Abstract][Full Text] [Related]
2. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus. Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048 [TBL] [Abstract][Full Text] [Related]
3. Humoral response to p53 is associated with conserved domains II and IV mutations in human colorectal cancer: a case-control study in Taiwan. Wu CM; Tang R; Chen JR; Wu MC; Chien HT; Changchien CR; Hsieh LL Oncol Rep; 2004 Nov; 12(5):1045-51. PubMed ID: 15492791 [TBL] [Abstract][Full Text] [Related]
4. p53 alterations are associated with improved prognosis in distal colonic carcinomas. Soong R; Grieu F; Robbins P; Dix B; Chen D; Parsons R; House A; Iacopetta B Clin Cancer Res; 1997 Aug; 3(8):1405-11. PubMed ID: 9815825 [TBL] [Abstract][Full Text] [Related]
5. Discordance of p53 mutations of synchronous colorectal carcinomas. Eguchi K; Yao T; Konomoto T; Hayashi K; Fujishima M; Tsuneyoshi M Mod Pathol; 2000 Feb; 13(2):131-9. PubMed ID: 10697269 [TBL] [Abstract][Full Text] [Related]
6. Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma. Chang SC; Lin JK; Lin TC; Liang WY Int J Oncol; 2005 Jan; 26(1):65-75. PubMed ID: 15586226 [TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic accumulation of p53 protein: an independent prognostic indicator in colorectal adenocarcinomas. Bosari S; Viale G; Bossi P; Maggioni M; Coggi G; Murray JJ; Lee AK J Natl Cancer Inst; 1994 May; 86(9):681-7. PubMed ID: 8158699 [TBL] [Abstract][Full Text] [Related]
8. Frequent p53 gene mutations in serrated adenomas of the colorectum. Hiyama T; Yokozaki H; Shimamoto F; Haruma K; Yasui W; Kajiyama G; Tahara E J Pathol; 1998 Oct; 186(2):131-9. PubMed ID: 9924427 [TBL] [Abstract][Full Text] [Related]
9. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance. Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410 [TBL] [Abstract][Full Text] [Related]
10. Telomerase activity and p53 gene mutation in familial polyposis coli. Ikeguchi M; Makino M; Kaibara N Anticancer Res; 2000; 20(5C):3833-7. PubMed ID: 11268463 [TBL] [Abstract][Full Text] [Related]
11. A study of stabilisation of p53 protein versus point mutation in colorectal carcinoma. Cripps KJ; Purdie CA; Carder PJ; White S; Komine K; Bird CC; Wyllie AH Oncogene; 1994 Sep; 9(9):2739-43. PubMed ID: 8058340 [TBL] [Abstract][Full Text] [Related]
12. K-ras and p53 gene mutations in colorectal cancer in 57 Japanese patients. Onda M; Abe R; Tsuchiya A; Fukushima T; Ando Y; Yoshida T Fukushima J Med Sci; 1997 Jun; 43(1):29-39. PubMed ID: 9431782 [TBL] [Abstract][Full Text] [Related]
13. p21WAF1/CIP1 expression in colorectal carcinoma correlates with advanced disease stage and p53 mutations. Viale G; Pellegrini C; Mazzarol G; Maisonneuve P; Silverman ML; Bosari S J Pathol; 1999 Feb; 187(3):302-7. PubMed ID: 10398083 [TBL] [Abstract][Full Text] [Related]
14. p53 nuclear accumulation and multiploidy are adverse prognostic factors in surgically resected stage II colorectal cancers independent of fluorouracil-based adjuvant therapy. Buglioni S; D'Agnano I; Vasselli S; Perrone Donnorso R; D'Angelo C; Brenna A; Benevolo M; Cosimelli M; Zupi G; Mottolese M Am J Clin Pathol; 2001 Sep; 116(3):360-8. PubMed ID: 11554164 [TBL] [Abstract][Full Text] [Related]
15. [Comparison of nuclear accumulation of p53 protein with mutations in the p53 gene on the tissues of human breast cancer]. Fan P; Wu Z; Cha X; Wang X; Wang S Zhonghua Wai Ke Za Zhi; 1998 Nov; 36(11):655-7. PubMed ID: 11825490 [TBL] [Abstract][Full Text] [Related]
16. Association of p53 mutations with metastatic prostate cancer. Eastham JA; Stapleton AM; Gousse AE; Timme TL; Yang G; Slawin KM; Wheeler TM; Scardino PT; Thompson TC Clin Cancer Res; 1995 Oct; 1(10):1111-8. PubMed ID: 9815901 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of four antibodies in detecting p53 protein for predicting clinicopathological and prognostic significance in colorectal adenocarcinoma. Zhang Hong Clin Cancer Res; 1999 Dec; 5(12):4126-32. PubMed ID: 10632350 [TBL] [Abstract][Full Text] [Related]
18. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer. Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of mutations to different structural and functional regions of the p53 gene in breast cancer. Powell B; Soong R; Iacopetta B; Seshadri R; Smith DR Clin Cancer Res; 2000 Feb; 6(2):443-51. PubMed ID: 10690522 [TBL] [Abstract][Full Text] [Related]
20. Have p53 gene mutations and protein expression a different biological significance in colorectal cancer? Bazan V; Migliavacca M; Tubiolo C; Macaluso M; Zanna I; Corsale S; Amato A; Calò V; Dardanoni G; Morello V; La Farina M; Albanese I; Tomasino RM; Gebbia N; Russo A J Cell Physiol; 2002 May; 191(2):237-46. PubMed ID: 12064467 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]